Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion

L. S. Rosen; D. H. Gordon; W. Dugan; D. Tripathy

Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion

L. S. Rosen, D. H. Gordon, W. Dugan, D. Tripathy

Breast Medical Oncology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	319-320
Number of pages	2
Journal	Breast Diseases
Volume	15
Issue number	3
State	Published - Dec 2004

ASJC Scopus subject areas

Surgery
Oncology

Cite this

@article{3780c833772b43d08991b98ec9556bac,

title = "Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion",

author = "Rosen, {L. S.} and Gordon, {D. H.} and W. Dugan and D. Tripathy",

year = "2004",

month = dec,

language = "English (US)",

volume = "15",

pages = "319--320",

journal = "Breast Diseases",

issn = "1043-321X",

publisher = "Academic Press Inc.",

number = "3",

}

TY - JOUR

T1 - Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion

AU - Rosen, L. S.

AU - Gordon, D. H.

AU - Dugan, W.

AU - Tripathy, D.

PY - 2004/12

Y1 - 2004/12

UR - http://www.scopus.com/inward/record.url?scp=4944241512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4944241512&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:4944241512

SN - 1043-321X

VL - 15

SP - 319

EP - 320

JO - Breast Diseases

JF - Breast Diseases

IS - 3

ER -

Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion

ASJC Scopus subject areas

Other files and links

Cite this